New Report Focuses on NASH Market Opportunity
It’s no surprise that many pharmaceutical companies are developing treatments for a disease affecting millions with no current therapy. That disease is Non-alcoholic fatty liver disease (NAFLD). NASH is a lifestyle disease (obesity and lack of exercise) and is distinct from other fatty liver diseases caused by alcohol abuse or medication side effects. The symptoms […]